Autism and Other Developmental Disabilities, Surveillance, Research, and Prevention
This funding supports State health agencies, universities, and public and private nonprofit organizations in planning, implementing, coordinating, or evaluating programs related to autism and other developmental disabilities and the improvement of infant and child health and developmental outcomes. Programs may include the following activities: conducting epidemiologic research or surveillance; providing a national, State or local platform in the area of autism and developmental disabilities prevention that focuses on improving early identification of children with autism and other developmental disabilities so children and families can get the services and support they need; enhancing existing research or surveillance programs to better address research questions, monitor changes in prevalence and contributing factors, and inform policy and program activities; employing epidemiological methods to set priorities, build capacity and direct health promotion interventions for persons with autism and other developmental disabilities; disseminating data and health information; employing strategies to reduce racial/ethnic disparities in the identification of autism and other developmental disabilities; and expanding public health training opportunities through fellowships to introduce geneticists, epidemiologists, and clinicians to public health practice through education, training and career-enhancing experiences.
General information about this opportunity
Last Known Status
Active
Program Number
93.998
Federal Agency/Office
Centers For Disease Control and Prevention, Department of Health and Human Services
Type(s) of Assistance Offered
B - Project Grants
Program Accomplishments
Not applicable.
Authorization
Public Health Service Act Section 317(k)(2), Title 42, Part 241(a), Section 301(a), 42 U.S.C 247b(k)(2)., Title 42, Part 241(A), Section 301(a)
Who is eligible to apply/benefit from this assistance?
Applicant Eligibility
Not applicable.
Beneficiary Eligibility
State; Consumer; Local; Public nonprofit institution/organization; Federally Recognized Indian Tribal Governments; Private nonprofit institution/organizations and others.
Credentials/Documentation
Not applicable.
What is the process for applying and being award this assistance?
Pre-Application Procedure
Preapplication coordination is not applicable.
Application Procedure
This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards.
Award Procedure
After review and approval, a Notice of Award from the CDC Office of Grant Services is prepared and signed by an authorized Grants Management Officer. The initial award provides funds for first budget period (usually 12 months) and Notice of Award indicates support recommended for the remainder of project period, allocation of Federal funds by budget categories, and special conditions, if any. Cooperative agreement awards and grants, competitive and single eligibility, are determined by an internal objective committee review process at CDC, including peer reviews for research activities. Awards will be based on evaluation criteria set forth in the respective Notice of Funding Opportunity, the availability of funds, and such other significant factors as deemed necessary and appropriate by CDC.
Deadlines
Contact the headquarters or regional location, as appropriate for application deadlines
Approval/Disapproval Decision Time
From 90 to 120 days.
Appeals
Not applicable.
Renewals
From 120 to 180 days. Project period of performance is 1 to 5 years. After initial awards, and subject to availability of funds, projects may be continued non-competitively contingent upon satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the Federal government.
How are proposals selected?
In general, applications are reviewed on the basis of scientific/technical merit, with attention given to such matters as: (1) The degree to which the applicant satisfies the essential requirements and possesses other desired characteristics, such as depth, breadth, and merit of the overall application relative to the types of projects proposed; (2) clarity of purpose and overall qualifications, adequacy and appropriateness of personnel to accomplish proposed prevention research projects and demonstration projects, and the nation's health priorities and needs; (3) ability to generalize, translate and disseminate to State or local health departments, and other appropriate national regional, and local public health agencies and organizations; (4) reasonableness of the proposed budget in relation to the work proposed.
How may assistance be used?
Funds may be used to strengthen, expand, build upon or enhance research, surveillance, health promotion, education, and prevention/intervention activities that contribute to the mission and activities of the Division of Human Development and Disability (DHDD). Funds may be used to improve and strengthen State and local public health infrastructure by providing technical assistance to other appropriate health agencies, organizations, special groups or coalitions. Funds may be used to support capacity building, program planning, development, implementation, evaluation, and surveillance for autism and other developmental disabilities, and infant and child health and developmental outcomes, including related health promotion, education and training, and prevention/intervention. Funds may also be used to coordinate the dissemination of prevention information to the general public, target populations, state and local agencies, and public and private sector organizations in the United States. Funds may not be used for direct curative or rehabilitative services.
What are the requirements after being awarded this opportunity?
Reporting
Performance Reports: Annual Federal Financial Reports (FFR) and performance/progress reports are required. Final FFRs and performance reports are required. Other reporting may be required and will be outlined in the NOFO or the Notice of Award.
Auditing
Not applicable.
Records
In accordance with 2 CFR ?200, as codified in 45 CFR ?75, there is a 3-year record retention requirement; records shall be retained beyond the 3-year period if final audit has not been done or findings resolved. Property records must be retained in accordance with HHS Grants Policy Statement requirements.
Other Assistance Considerations
Formula and Matching Requirements
Statutory formula is not applicable to this assistance listing.
Matching requirements are not applicable to this assistance listing.
MOE requirements are not applicable to this assistance listing.
Length and Time Phasing of Assistance
Financial assistance is provided for a 12-month budget period with a period of performance of up to five years subject to the availability of funds and satisfactory progress of the recipient. Notice of Award
Who do I contact about this opportunity?
Regional or Local Office
None/Not specified.
Headquarters Office
Bruce Heath
4770 Buford Hwy., MS-E86
Atlanta, GA 30341 US
rbh5@cdc.gov
Phone: 404-639-1938
Shelia Jones
4770 Buford Highway
Mailstop E87
Atlanta, GA 30341 USA
sjones3@cdc.gov
Phone: 404-498-3995
Financial Information
Account Identification
75-0958-1-1-550
Obligations
(Cooperative Agreements) FY 22$4,250,347.00; FY 23 est $7,930,191.00; FY 24 est $7,930,191.00; FY 21$4,500,000.00; FY 20$4,500,000.00; FY 19$4,200,000.00; FY 17$5,099,939.00; FY 18 est $5,099,939.00; FY 16$5,624,841.00; -
Range and Average of Financial Assistance
Award amount range is $387,000-$570,000. Average award - $450,000
Regulations, Guidelines and Literature
Successful applicants must comply with the administrative requirements outlined in 45 Code of Federal Regulations (CFR) Part 75. Additional requirements are described in the HHS Grants Policy Statement.
Examples of Funded Projects
Not applicable.